Neves, Andreia R.; Ensina, Luis Felipe C.; Anselmo, Luciene B.; Leite, Katia R. M.; Buzaid, Antonio C.; Câmara-Lopes, Luiz H.; Barbuto, José Alexandre Marzagão 
Source: Cancer Immunology Immunotherapy. Unidade: ICB
Assunto: IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NEVES, Andreia R. et al. Dendritic cells derived from metastatic cancer patients vaccinated with allogenic dendritic cell-autologous tumor cell hybrids express more CD86 and induce higher levels of interferon-gamma in mixed lymphocyte reactions. Cancer Immunology Immunotherapy, v. 54, p. 61-66, 2005Tradução . . Disponível em: https://doi.org/10.1007/s00262-004-0550-8. Acesso em: 29 set. 2024.APA
Neves, A. R., Ensina, L. F. C., Anselmo, L. B., Leite, K. R. M., Buzaid, A. C., Câmara-Lopes, L. H., & Barbuto, J. A. M. (2005). Dendritic cells derived from metastatic cancer patients vaccinated with allogenic dendritic cell-autologous tumor cell hybrids express more CD86 and induce higher levels of interferon-gamma in mixed lymphocyte reactions. Cancer Immunology Immunotherapy, 54, 61-66. doi:10.1007/s00262-004-0550-8NLM
Neves AR, Ensina LFC, Anselmo LB, Leite KRM, Buzaid AC, Câmara-Lopes LH, Barbuto JAM. Dendritic cells derived from metastatic cancer patients vaccinated with allogenic dendritic cell-autologous tumor cell hybrids express more CD86 and induce higher levels of interferon-gamma in mixed lymphocyte reactions [Internet]. Cancer Immunology Immunotherapy. 2005 ; 54 61-66.[citado 2024 set. 29 ] Available from: https://doi.org/10.1007/s00262-004-0550-8Vancouver
Neves AR, Ensina LFC, Anselmo LB, Leite KRM, Buzaid AC, Câmara-Lopes LH, Barbuto JAM. Dendritic cells derived from metastatic cancer patients vaccinated with allogenic dendritic cell-autologous tumor cell hybrids express more CD86 and induce higher levels of interferon-gamma in mixed lymphocyte reactions [Internet]. Cancer Immunology Immunotherapy. 2005 ; 54 61-66.[citado 2024 set. 29 ] Available from: https://doi.org/10.1007/s00262-004-0550-8
